(NASDAQ: LFCR) Lifecore Biomedical's forecast annual revenue growth rate of 22.96% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 12.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.86%.
Lifecore Biomedical's revenue in 2024 is $103,269,000.On average, 1 Wall Street analysts forecast LFCR's revenue for 2024 to be $3,878,819,386, with the lowest LFCR revenue forecast at $3,878,819,386, and the highest LFCR revenue forecast at $3,878,819,386.
In 2025, LFCR is forecast to generate $4,460,646,876 in revenue, with the lowest revenue forecast at $4,460,646,876 and the highest revenue forecast at $4,460,646,876.